跳至主要内容
临床试验/NCT04613479
NCT04613479Unknown不适用

Frequency of Hepatobilliary Manifestations in Patients With Inflammatory Bowel Disease

Assiut University0 个研究点目标入组 60 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
主要终点
The prevelance of hepatobilliary manifestations in IBD patients

研究概览

简要总结

Hepatobilliary manifestations as extraintestinal manifestations of IBD are sometimes underdiagnosed which can impair patient prognosis

详细描述

Non alcoholic fatty liver is aliver disease most commonly found in patient with IBD most commonly without intestinal activity.

On the other hand primary according cholangitis is the most common specific with IBD commonly with ulcerative colitis. and is commonly overlap with autoimmune hepatitis IBD therapy can also be a cause it can lead to hepatic toxicity and some drugs like ant TNF can cause hepatitis b virus activation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • all patients diagnosed IBD crohns and ulcerative on conventional treatment and biological treatment -

排除标准

  • 未提供

结局指标

主要结局

The prevelance of hepatobilliary manifestations in IBD patients

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hayam Fathy Nasr

clinical doctor internal medicine

Assiut University

相似试验